Showing results (491-500 of 500) with videos related to
Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 500 results.
Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.Blood|February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomesMichael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.Nature|August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.Nature|June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.Cell|November 10, 2020
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Yapeng Su, Daniel Chen, Dan Yuan, et al.The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.Lancet (London, England)|May 25, 2020
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Paul N Harden, Petra Reinke, et al.Frontiers in Immunology|January 31, 2018
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and StandardizationAnke Fuchs, Mateusz Gliwiński, Nathali Grageda, et al.Cell|February 26, 2022
Multiple early factors anticipate post-acute COVID-19 sequelaeYapeng Su, Dan Yuan, Daniel G Chen, et al.Pageof 50